Loading...
Canagliflozin, a sodium–glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats
AIMS/INTRODUCTION: Type 2 diabetes mellitus is a risk factor of acute kidney injury after myocardial infarction (MI), a form of cardiorenal syndrome. Recent clinical trials have shown that a sodium–glucose cotransporter 2 (SGLT2) inhibitor improved both cardiac and renal outcomes in patients with ty...
Na minha lista:
| Udgivet i: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626958/ https://ncbi.nlm.nih.gov/pubmed/30663266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13009 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|